An article published in November in BioMed Central discovered serious differences between studies funded by pharmaceutical companies selling testosterone therapy drugs, and those that were independent of pharmaceutical companies pushing the drugs. Combined with the FDA warning1 in January on the risks of testosterone therapy, including heart attacks and strokes, this paints a troubling picture […]

On January 31, 2014 the FDA published a warning on the risks of testosterone therapy1. This warning prompted news organizations to cover stories about these new risks, and now prominent consumer productions agencies are calling for changes to the warning labels of testosterone therapy products2. Public Citizen is a consumer advocacy organization with more than […]